LIVE

Onesource Specialty Pharma Ltd

ONESOURCE

Coverage

OneSource Q1 Revenue Jumps 37% on Semaglutide Launch; FY28 $400M Target Reaffirmed

INFORMED AI-assisted reporting, deterministically source-verified before publication.

About Editorial standards Corrections Ownership Contact Masthead

Home Search Feeds Saved Me